Miranda van Eck is Professor of Cardiovascular and Metabolic Therapeutics and Scientific Director of the Leiden Academic Centre for Drug Research (LACDR). She has held the position of Scientific Director since September 2024 and previously served for 12 years as Director of the master programme Bio-Pharmaceutical Sciences. In addition, she is chair of the Dutch Council for Pharmaceutical Sciences, executive board member of the European Pharmaceutical Sciences consortium ULLA, board member of PharmaNL, and board member of the Biotech Training Facility in Leiden.

Prof. Van Eck obtained her PhD from Leiden University in 1999 and is internationally recognized for her research on HDL metabolism, macrophage biology, and the identification of novel therapeutic targets for cardiovascular and metabolic diseases. She has authored more than 160 peer-reviewed publications and has received numerous competitive research grants, including the VIDI and VICI Innovation Research grants from the Netherlands Organisation for Scientific Research (NWO). Her contributions have been recognized with several prestigious awards, including the Galenus Research Prize and two International HDL Research Award Program awards. Since 2008, she has been an Established Investigator of the Netherlands Heart Foundation.

As Chair of the Council for Pharmaceutical Sciences, Prof. Van Eck is leading the development of a new sector overview of Pharmaceutical Sciences in the Netherlands.